Literature DB >> 28317064

Altered synchrony of right ventricular contraction in borderline pulmonary hypertension.

Bouchra Lamia1,2,3, Jean-François Muir4, Luis-Carlos Molano5, Catherine Viacroze5, Jacques Benichou6, Philippe Bonnet7, Jean Quieffin8, Antoine Cuvelier4, Robert Naeije9.   

Abstract

Imaging studies have shown that pulmonary hypertension (PH) is associated with inhomogenous right ventricular (RV) regional contraction, or dyssynchrony, and that this is of prognostic relevance. This study aimed at the identification and functional significance of RV dyssynchrony in borderline PH defined by a mean pulmonary artery pressure between (mPAP) 20 and 25 mmHg. RV dyssynchrony was measured by 2-dimensional speckle tracking echocardiography in 17 patients with pulmonary arterial hypertension (PAH), 13 patients with borderline PH and 14 controls. Dyssynchrony was defined as the R-R interval-corrected standard deviation of the times to peak-systolic strain for the basal and medium segments of the RV. All the PH patients underwent a right heart catheterization. RV dyssynchrony amounted to 69 ± 34 ms in PAH, 47 ± 23 ms in borderline PH and 8 ± 6 ms in controls, all different from each other (p < 0.05). RV dyssynchrony in borderline PH was the only parameter of RV systolic dysfunction in 11 of 13 (85%) of the patients. RV dyssynchrony was accompanied by postsystolic shortening and correlated to RV fractional area change, not to mPAP or pulmonary vascular resistance. RV dyssynchrony occurs in borderline PH and may reflect early RV-arterial uncoupling.

Entities:  

Keywords:  Dyssynchrony; Postsystolic shortening; Pulmonary circulation; Pulmonary hypertension; Right ventricle; Speckle tracking echocardiography

Mesh:

Year:  2017        PMID: 28317064     DOI: 10.1007/s10554-017-1110-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  31 in total

1.  Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension?

Authors:  S Huez; F Roufosse; J-L Vachiéry; A Pavelescu; G Derumeaux; J-C Wautrecht; E Cogan; R Naeije
Journal:  Eur Respir J       Date:  2007-08-09       Impact factor: 16.671

Review 2.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Relation of right ventricular free wall mechanical delay to right ventricular dysfunction as determined by tissue Doppler imaging.

Authors:  Angel López-Candales; Kaoru Dohi; Raveen Bazaz; Kathy Edelman
Journal:  Am J Cardiol       Date:  2005-08-15       Impact factor: 2.778

5.  Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.

Authors:  Janne Mykland Hilde; Ingunn Skjørten; Ole Jørgen Grøtta; Viggo Hansteen; Morten Nissen Melsom; Jonny Hisdal; Sjur Humerfelt; Kjetil Steine
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

6.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

7.  Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension.

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Nico Westerhof; Frances S de Man; Anco Boonstra; Martijn W Heymans; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

8.  Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension.

Authors:  Benjamin C F Smith; Gary Dobson; David Dawson; Athanasios Charalampopoulos; Julia Grapsa; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

9.  Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function.

Authors:  Roberto Badagliacca; Roberto Poscia; Beatrice Pezzuto; Silvia Papa; Cristina Gambardella; Marco Francone; Mario Mezzapesa; Martina Nocioni; Alfred Nona; Riccardo Rosati; Susanna Sciomer; Francesco Fedele; Carmine Dario Vizza
Journal:  J Heart Lung Transplant       Date:  2014-06-21       Impact factor: 10.247

10.  Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study.

Authors:  Scott H Visovatti; Oliver Distler; J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; James R Seibold; Juan-Vicente Torres-Martin; Martin Doelberg; Harbajan Chadha-Boreham; Daniel M Rosenberg; Vallerie V McLaughlin; Dinesh Khanna
Journal:  Arthritis Res Ther       Date:  2014-12-10       Impact factor: 5.156

View more
  8 in total

1.  The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension.

Authors:  Rebecca R Vanderpool; Kendall S Hunter; Michael Insel; Joe G N Garcia; Edward J Bedrick; Ryan J Tedford; Franz P Rischard
Journal:  Chest       Date:  2021-10-09       Impact factor: 10.262

2.  Right ventricle performances with echocardiography and 99mTc myocardial perfusion imaging in pulmonary arterial hypertension patients.

Authors:  Jie Liu; Lei Fei; Guang-Qing Huang; Xiao-Ke Shang; Mei Liu; Zhi-Jun Pei; Yong-Xue Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

3.  Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.

Authors:  Bradley A Maron; Bradley M Wertheim; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 30.528

Review 4.  The physiological basis of pulmonary arterial hypertension.

Authors:  Robert Naeije; Manuel J Richter; Lewis J Rubin
Journal:  Eur Respir J       Date:  2022-06-16       Impact factor: 33.795

5.  Preliminary Study of Right Ventricular Dyssynchrony Under High-Altitude Exposure: Determinants and Impacts.

Authors:  Yuanqi Yang; Chuan Liu; Jingdu Tian; Xiaohan Ding; Shiyong Yu; Shizhu Bian; Jie Yang; Zhexue Qin; Jihang Zhang; Jingbin Ke; Fangzhengyuan Yuan; Chen Zhang; Rongsheng Rao; Lan Huang
Journal:  Front Physiol       Date:  2020-07-02       Impact factor: 4.566

6.  Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis.

Authors:  Yangyi Lin; Lingpin Pang; Shian Huang; Jieyan Shen; Weifeng Wu; Fangming Tang; Weiqing Su; Xiulong Zhu; Jingzhi Sun; Ruilin Quan; Tao Yang; Huijun Han; Jianguo He
Journal:  Front Cardiovasc Med       Date:  2022-08-12

7.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.

Authors:  Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

8.  Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis.

Authors:  Sandra de Barros Cobra; Marcelo Palmeira Rodrigues; Felipe Xavier de Melo; Nathali Mireise Costa Ferreira; César Augusto Melo-Silva
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.